• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

深入研究 Moloney 鼠白血病病毒(Pim)激酶原病毒整合位点(Pim)与泛 Pim 抑制剂 PIM447 和 AZD1208 的相互作用机制:分子动力学模拟和 MM/GBSA 计算研究。

Insights into the Interaction Mechanisms of the Proviral Integration Site of Moloney Murine Leukemia Virus (Pim) Kinases with Pan-Pim Inhibitors PIM447 and AZD1208: A Molecular Dynamics Simulation and MM/GBSA Calculation Study.

机构信息

Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou 221004, China.

出版信息

Int J Mol Sci. 2019 Oct 30;20(21):5410. doi: 10.3390/ijms20215410.

DOI:10.3390/ijms20215410
PMID:31671637
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6862308/
Abstract

Based on the up-regulation of the proviral integration site of the Moloney murine leukemia virus (Pim) kinase family (Pim1, 2, and 3) observed in several types of leukemias and lymphomas, the development of pan-Pim inhibitors is an attractive therapeutic strategy. While only PIM447 and AZD1208 have entered the clinical stages. To elucidate the interaction mechanisms of three Pim kinases with PIM447 and AZD1208, six Pim/ligand systems were studied by homology modeling, molecular docking, molecular dynamics (MD) simulation and molecular mechanics/generalized Born surface area (MM/GBSA) binding free energy calculation. The residues of the top group (Leu44, Val52, Ala65, Lys67, and Leu120 in Pim1) dominated the pan-Pim inhibitors binding to Pim kinases. The residues of the bottom group (Gln127, Asp128, and Leu174 in Pim1) were crucial for Pims/PIM447 systems, while the contributions of these residues were decreased sharply for Pims/AZD1208 systems. It is likely that the more potent pan-Pim inhibitors should be bound strongly to the top and bottom groups. The residues of the left, right and loop groups were located in the loop regions of the binding pocket, however, the flexibility of these regions triggered the protein interacting with diverse pan-Pim inhibitors efficiently. We hope this work can provide valuable information for the design of novel pan-Pim inhibitors in the future.

摘要

基于 Moloney 鼠白血病病毒(Pim)激酶家族(Pim1、2 和 3)原病毒整合位点在几种类型的白血病和淋巴瘤中上调的观察结果,开发泛 Pim 抑制剂是一种有吸引力的治疗策略。虽然只有 PIM447 和 AZD1208 进入了临床阶段。为了阐明三种 Pim 激酶与 PIM447 和 AZD1208 的相互作用机制,通过同源建模、分子对接、分子动力学(MD)模拟和分子力学/广义 Born 表面积(MM/GBSA)结合自由能计算研究了六个 Pim/配体系统。通过同源建模、分子对接、分子动力学(MD)模拟和分子力学/广义 Born 表面积(MM/GBSA)结合自由能计算研究了六个 Pim/配体系统。通过同源建模、分子对接、分子动力学(MD)模拟和分子力学/广义 Born 表面积(MM/GBSA)结合自由能计算研究了六个 Pim/配体系统。处于顶部组(Pim1 中的 Leu44、Val52、Ala65、Lys67 和 Leu120)的残基主导着泛 Pim 抑制剂与 Pim 激酶的结合。底部组(Pim1 中的 Gln127、Asp128 和 Leu174)的残基对于 Pims/PIM447 系统至关重要,而对于 Pims/AZD1208 系统,这些残基的贡献急剧下降。很可能更有效的泛 Pim 抑制剂应该与顶部和底部基团紧密结合。左侧、右侧和环组的残基位于结合口袋的环区域,然而,这些区域的灵活性触发了蛋白质与不同的泛 Pim 抑制剂有效相互作用。我们希望这项工作能为未来设计新型泛 Pim 抑制剂提供有价值的信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adaf/6862308/d8c83ed93a53/ijms-20-05410-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adaf/6862308/bf365a3df0d1/ijms-20-05410-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adaf/6862308/bd1cbd5080f2/ijms-20-05410-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adaf/6862308/9653df00acd4/ijms-20-05410-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adaf/6862308/8f4b9324db78/ijms-20-05410-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adaf/6862308/0e9cb28dfe47/ijms-20-05410-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adaf/6862308/c16b1ea38006/ijms-20-05410-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adaf/6862308/d8c83ed93a53/ijms-20-05410-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adaf/6862308/bf365a3df0d1/ijms-20-05410-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adaf/6862308/bd1cbd5080f2/ijms-20-05410-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adaf/6862308/9653df00acd4/ijms-20-05410-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adaf/6862308/8f4b9324db78/ijms-20-05410-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adaf/6862308/0e9cb28dfe47/ijms-20-05410-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adaf/6862308/c16b1ea38006/ijms-20-05410-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adaf/6862308/d8c83ed93a53/ijms-20-05410-g007.jpg

相似文献

1
Insights into the Interaction Mechanisms of the Proviral Integration Site of Moloney Murine Leukemia Virus (Pim) Kinases with Pan-Pim Inhibitors PIM447 and AZD1208: A Molecular Dynamics Simulation and MM/GBSA Calculation Study.深入研究 Moloney 鼠白血病病毒(Pim)激酶原病毒整合位点(Pim)与泛 Pim 抑制剂 PIM447 和 AZD1208 的相互作用机制:分子动力学模拟和 MM/GBSA 计算研究。
Int J Mol Sci. 2019 Oct 30;20(21):5410. doi: 10.3390/ijms20215410.
2
New Mechanistic Insight on the PIM-1 Kinase Inhibitor AZD1208 Using Multidrug Resistant Human Erythroleukemia Cell Lines and Molecular Docking Simulations.多药耐药人红白血病细胞系和分子对接模拟对 PIM-1 激酶抑制剂 AZD1208 的新作用机制研究。
Curr Top Med Chem. 2019;19(11):914-926. doi: 10.2174/1568026619666190509121606.
3
AZD1208, a Pan-Pim Kinase Inhibitor, Has Anti-Growth Effect on 93T449 Human Liposarcoma Cells via Control of the Expression and Phosphorylation of Pim-3, mTOR, 4EBP-1, S6, STAT-3 and AMPK.AZD1208,一种泛 Pim 激酶抑制剂,通过控制 Pim-3、mTOR、4EBP-1、S6、STAT-3 和 AMPK 的表达和磷酸化,对 93T449 人脂肪肉瘤细胞具有抗生长作用。
Int J Mol Sci. 2019 Jan 16;20(2):363. doi: 10.3390/ijms20020363.
4
AZD1208, a pan-Pim kinase inhibitor, inhibits adipogenesis and induces lipolysis in 3T3-L1 adipocytes.AZD1208,一种泛 Pim 激酶抑制剂,可抑制 3T3-L1 脂肪细胞的脂肪生成并诱导脂肪分解。
J Cell Mol Med. 2018 Apr;22(4):2488-2497. doi: 10.1111/jcmm.13559. Epub 2018 Feb 14.
5
Pan-Pim Kinase Inhibitor AZD1208 Suppresses Tumor Growth and Synergistically Interacts with Akt Inhibition in Gastric Cancer Cells.泛 Pim 激酶抑制剂 AZD1208 抑制胃癌细胞的肿瘤生长并与 Akt 抑制协同作用。
Cancer Res Treat. 2019 Apr;51(2):451-463. doi: 10.4143/crt.2017.341. Epub 2018 Jun 6.
6
AZD1208, a potent and selective pan-Pim kinase inhibitor, demonstrates efficacy in preclinical models of acute myeloid leukemia.AZD1208,一种强效和选择性的全 Pim 激酶抑制剂,在急性髓系白血病的临床前模型中显示出疗效。
Blood. 2014 Feb 6;123(6):905-13. doi: 10.1182/blood-2013-04-495366. Epub 2013 Dec 20.
7
The novel combination of dual mTOR inhibitor AZD2014 and pan-PIM inhibitor AZD1208 inhibits growth in acute myeloid leukemia via HSF pathway suppression.双mTOR抑制剂AZD2014与泛PIM抑制剂AZD1208的新型组合通过抑制HSF途径抑制急性髓系白血病的生长。
Oncotarget. 2015 Nov 10;6(35):37930-47. doi: 10.18632/oncotarget.6122.
8
2-Thioxothiazolidin-4-one Analogs as Pan-PIM Kinase Inhibitors.2-硫代噻唑烷-4-酮类似物作为泛 PIM 激酶抑制剂。
Chem Pharm Bull (Tokyo). 2021;69(9):854-861. doi: 10.1248/cpb.c21-00264.
9
3D QSAR studies, molecular docking and ADMET evaluation, using thiazolidine derivatives as template to obtain new inhibitors of PIM1 kinase.基于噻唑烷衍生物模板的 3D QSAR 研究、分子对接和 ADMET 评估,以获得新的 PIM1 激酶抑制剂。
Comput Biol Chem. 2018 Jun;74:201-211. doi: 10.1016/j.compbiolchem.2018.03.008. Epub 2018 Mar 12.
10
Loss of PIM2 enhances the anti-proliferative effect of the pan-PIM kinase inhibitor AZD1208 in non-Hodgkin lymphomas.PIM2缺失增强了泛PIM激酶抑制剂AZD1208在非霍奇金淋巴瘤中的抗增殖作用。
Mol Cancer. 2015 Dec 8;14:205. doi: 10.1186/s12943-015-0477-z.

引用本文的文献

1
Elucidating the linagliptin and fibroblast activation protein binding mechanism through molecular dynamics and binding free energy analysis.通过分子动力学和结合自由能分析阐明利那格列汀与成纤维细胞活化蛋白的结合机制。
iScience. 2024 Nov 13;27(12):111368. doi: 10.1016/j.isci.2024.111368. eCollection 2024 Dec 20.
2
AUM302, a novel triple kinase PIM/PI3K/mTOR inhibitor, is a potent in vitro pancreatic cancer growth inhibitor.AUM302 是一种新型的三激酶 PIM/PI3K/mTOR 抑制剂,是一种有效的体外胰腺癌生长抑制剂。
PLoS One. 2023 Nov 9;18(11):e0294065. doi: 10.1371/journal.pone.0294065. eCollection 2023.
3
Selectivity Mechanism of Pyrrolopyridone Analogues Targeting Bromodomain 2 of Bromodomain-Containing Protein 4 from Molecular Dynamics Simulations.

本文引用的文献

1
Assessing the performance of three resveratrol in binding with SIRT1 by molecular dynamics simulation and MM/GBSA methods: the weakest binding of resveratrol 3 to SIRT1 triggers a possibility of dissociation from its binding site.通过分子动力学模拟和 MM/GBSA 方法评估三种白藜芦醇与 SIRT1 结合的性能:白藜芦醇 3 与 SIRT1 的结合最弱,有可能从其结合位点解离。
J Comput Aided Mol Des. 2019 Apr;33(4):437-446. doi: 10.1007/s10822-019-00193-0. Epub 2019 Feb 25.
2
Optimization of Pan-Pim Kinase Activity and Oral Bioavailability Leading to Diaminopyrazole (GDC-0339) for the Treatment of Multiple Myeloma.泛 Pim 激酶活性优化和口服生物利用度提高导致二氨基吡唑(GDC-0339)用于多发性骨髓瘤的治疗。
J Med Chem. 2019 Feb 28;62(4):2140-2153. doi: 10.1021/acs.jmedchem.8b01857. Epub 2019 Feb 20.
3
基于分子动力学模拟的吡咯并吡啶酮类似物靶向含溴结构域蛋白4的溴结构域2的选择性机制
ACS Omega. 2023 Sep 6;8(37):33658-33674. doi: 10.1021/acsomega.3c03935. eCollection 2023 Sep 19.
4
Interactions between curcumin and human salt-induced kinase 3 elucidated from computational tools and experimental methods.通过计算工具和实验方法阐明姜黄素与人类盐诱导激酶3之间的相互作用。
Front Pharmacol. 2023 Apr 13;14:1116098. doi: 10.3389/fphar.2023.1116098. eCollection 2023.
5
Inhibition of PIM Kinases Promotes Neuroblastoma Cell Differentiation to a Neuronal Phenotype.抑制 PIM 激酶可促进神经母细胞瘤细胞向神经元表型分化。
J Pediatr Surg. 2023 Jun;58(6):1155-1163. doi: 10.1016/j.jpedsurg.2023.02.018. Epub 2023 Feb 17.
6
'Targeting' the search: An upgraded structural and functional repository of antimicrobial peptides for biofilm studies (B-AMP v2.0) with a focus on biofilm protein targets.“靶向”搜索:一个升级的抗菌肽结构和功能数据库,用于生物膜研究(B-AMP v2.0),重点是生物膜蛋白靶标。
Front Cell Infect Microbiol. 2022 Oct 18;12:1020391. doi: 10.3389/fcimb.2022.1020391. eCollection 2022.
7
The Role of PIM Kinases in Pediatric Solid Tumors.PIM激酶在儿童实体瘤中的作用。
Cancers (Basel). 2022 Jul 22;14(15):3565. doi: 10.3390/cancers14153565.
8
Stabilization of PIM Kinases in Hypoxia Is Mediated by the Deubiquitinase USP28.缺氧条件下 PIM 激酶的稳定是由去泛素化酶 USP28 介导的。
Cells. 2022 Mar 16;11(6):1006. doi: 10.3390/cells11061006.
9
The Physical Chemistry and Chemical Physics (PCCP) Section of the in Its Publications: The First 300 Thematic Articles in the First 3 Years.期刊《物理化学杂志 C 辑:化学物理学》(PCCP)出版之出版物特色:创刊前 3 年的前 300 篇专题文章。
Int J Mol Sci. 2021 Dec 27;23(1):241. doi: 10.3390/ijms23010241.
10
Computational Insights Into the Effects of the R190K and N121Q Mutations on the SARS-CoV-2 Spike Complex With Biliverdin.关于R190K和N121Q突变对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突复合物与胆红素影响的计算洞察
Front Mol Biosci. 2021 Dec 13;8:791885. doi: 10.3389/fmolb.2021.791885. eCollection 2021.
Computational insights into the interaction mechanism of transcription cofactor vestigial-like protein 4 binding to TEA domain transcription factor 4 by molecular dynamics simulation and molecular mechanics generalized Born/surface area) calculation.通过分子动力学模拟和分子力学广义 Born/表面积计算,深入了解转录辅助因子遗迹样蛋白 4 与 TEA 结构域转录因子 4 相互作用的机制。
J Biomol Struct Dyn. 2019 Jul;37(10):2538-2545. doi: 10.1080/07391102.2018.1491889. Epub 2018 Nov 9.
4
Preclinical characterization of INCB053914, a novel pan-PIM kinase inhibitor, alone and in combination with anticancer agents, in models of hematologic malignancies.在血液系统恶性肿瘤模型中单独及联合抗癌药物对新型泛 PIM 激酶抑制剂 INCB053914 的临床前特征进行研究。
PLoS One. 2018 Jun 21;13(6):e0199108. doi: 10.1371/journal.pone.0199108. eCollection 2018.
5
Homology modeling and docking studies of a Δ9-fatty acid desaturase from a Cold-tolerant sp. AMS8.来自耐冷菌AMS8的Δ9-脂肪酸去饱和酶的同源建模与对接研究
PeerJ. 2018 Mar 19;6:e4347. doi: 10.7717/peerj.4347. eCollection 2018.
6
Discovery of 5-Azaindazole (GNE-955) as a Potent Pan-Pim Inhibitor with Optimized Bioavailability.发现5-氮杂吲哚(GNE-955)作为一种具有优化生物利用度的强效泛Pim抑制剂。
J Med Chem. 2017 May 25;60(10):4458-4473. doi: 10.1021/acs.jmedchem.7b00418. Epub 2017 May 5.
7
Identification of N-(4-((1R,3S,5S)-3-Amino-5-methylcyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide (PIM447), a Potent and Selective Proviral Insertion Site of Moloney Murine Leukemia (PIM) 1, 2, and 3 Kinase Inhibitor in Clinical Trials for Hematological Malignancies.N-(4-((1R,3S,5S)-3-氨基-5-甲基环己基)吡啶-3-基)-6-(2,6-二氟苯基)-5-氟吡啶甲酰胺(PIM447)的鉴定,PIM447是一种强效且选择性的莫洛尼氏鼠白血病病毒(PIM)1、2和3激酶抑制剂,正用于血液系统恶性肿瘤的临床试验。
J Med Chem. 2015 Nov 12;58(21):8373-86. doi: 10.1021/acs.jmedchem.5b01275. Epub 2015 Oct 27.
8
Total Synthesis of Hispidulin and the Structural Basis for Its Inhibition of Proto-oncogene Kinase Pim-1.希皮素的全合成及对原癌基因激酶 Pim-1 抑制作用的结构基础。
J Nat Prod. 2015 Aug 28;78(8):1969-76. doi: 10.1021/acs.jnatprod.5b00324. Epub 2015 Aug 14.
9
The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities.用于估计配体结合亲和力的MM/PBSA和MM/GBSA方法。
Expert Opin Drug Discov. 2015 May;10(5):449-61. doi: 10.1517/17460441.2015.1032936. Epub 2015 Apr 2.
10
The discovery of novel 3-(pyrazin-2-yl)-1H-indazoles as potent pan-Pim kinase inhibitors.新型3-(吡嗪-2-基)-1H-吲唑作为强效泛Pim激酶抑制剂的发现。
Bioorg Med Chem Lett. 2015 Feb 15;25(4):834-40. doi: 10.1016/j.bmcl.2014.12.068. Epub 2014 Dec 30.